“Whistleblower” Cases Reflect Evidence, Not Personality, Prosecutor Says
Executive Summary
A federal prosecutor's decision to intervene in "whistleblower" cases is tied to the quality of the information, not the quality of the individual, Philadelphia Associate U.S. Attorney James Sheehan told the Drug Information Association annual meeting in San Antonio June 17
You may also be interested in...
Medco Puts Number On DoJ Case: Settlement Should Be Less Than $42.5 Mil.
Medco hopes to resolve the Philadelphia U.S. Attorney's False Claims Act litigation for less than the $42.5 mil. the company has agreed to pay in a private class-action suit raising similar allegations
Medco Puts Number On DoJ Case: Settlement Should Be Less Than $42.5 Mil.
Medco hopes to resolve the Philadelphia U.S. Attorney's False Claims Act litigation for less than the $42.5 mil. the company has agreed to pay in a private class-action suit raising similar allegations
IG Pharma Compliance Guide Has First Amendment Flaws, Attorney Says
The HHS Inspector General's pharmaceutical compliance guide may be the next battleground for First Amendment cases, Wiley, Rein & Fielding Attorney John Kamp said at an OIG compliance guide symposium in Princeton, N.J. July 23